Skip to content
Disclosery

EXANE DERIVATIVES: GH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 69 GH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 69 shares
    Change vs previous 13F -815 shares

    <0.01% of the 13F portfolio, value $2,783.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 884 shares
    Change vs previous 13F -177 shares

    0.02% of the 13F portfolio, value $58,553.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,061 shares
    Change vs previous 13F -1,405 shares

    0.03% of the 13F portfolio, value $106,117.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,466 shares
    Change vs previous 13F -226 shares

    0.08% of the 13F portfolio, value $308,264.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,692 shares
    Change vs previous 13F -522 shares

    0.08% of the 13F portfolio, value $325,886.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,214 shares
    Change vs previous 13F -1,394 shares

    0.15% of the 13F portfolio, value $490,595.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,608 shares
    Change vs previous 13F +2,878 shares

    0.18% of the 13F portfolio, value $593,852.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,730 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $193,369.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).